Carfilzomib: A cause of drug associated thrombotic microangiopathy

Transfusion and Apheresis Science

Volumn 54, Issue 3, 2016, Pages 401-404

  Qaqish, Ibrahim ^a   Schlam, Ilana M ^a   Chakkera, Harini A ^a   Fonseca, Rafael ^a   Adamski, Jill ^a  

^a MAYO CLINIC   (United States)

Author keywords

Apheresis; Therapeutic plasma exchange; Thrombotic microangiopathy

Indexed keywords

BORTEZOMIB; CARFILZOMIB; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HEMOGLOBIN; LENALIDOMIDE; THALIDOMIDE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; OLIGOPEPTIDE;

AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FAINTNESS; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NEUROPATHY; OUTCOME ASSESSMENT; PLASMAPHERESIS; PNEUMONIA; STEM CELL TRANSPLANTATION; THROMBOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; VITREOUS HEMORRHAGE; CHEMICALLY INDUCED; PLASMA EXCHANGE; THROMBOTIC MICROANGIOPATHIES;

AGED; FEMALE; HUMANS; MALE; MULTIPLE MYELOMA; OLIGOPEPTIDES; PLASMA EXCHANGE; THROMBOTIC MICROANGIOPATHIES;

EID: 84962530615     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.03.002     Document Type: Article

References (21)

1. George JN, Charania RS Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost 2013, 39:153-160.
2. Kreuter J, Winters JL Drug-associated thrombotic microangiopathies. Semin Thromb Hemost 2012, 38:839-844.
3. Barbour T, Johnson S, Cohney S, Hughes P Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant 2012, 27:2673-2685.
4. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013, 28:145-284.
5. Morita R, Hashino S, Shirai S, Fujita N, Onozawa M, Kahata K, et al. Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma. Int J Hematol 2008, 88:248-250.
6. Moore H, Romeril K Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib. Intern Med J 2011, 41:348-350.
7. Salmenniemi U, Remes K Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma. Hematol Rep 2012, 4:e13.
8. Mehta N, Saxena A, Niesvizky R Bortezomib-induced thrombotic thrombocytopaenic purpura. BMJ Case Rep 2012, 2012. 10.1136/bcr-2012-006461.
9. Chan KL, Filshie R, Nandurkar H, Quach H Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma. Leuk Lymphoma 2015, 56:2185-2186. 10.3109/10428194.2014.977887.
10. Kortuem KM, Stewart AK Carfilzomib. Blood 2013, 121:893-897.
11. Siegel D, Martin T, Nooka A, Harvey RD, Vij R, Niesvizky R, et al. Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies. Haematologica 2013, 98:1753-1761.
12. Sullivan MR, Danilov AV, Lansigan F, Dunbar NM Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange. J Clin Apher 2015, 30:308-310.
13. Hobeika L, Self SE, Velez JC Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma. BMC Nephrol 2014, 15:156. 10.1186/1471-2369-15-156.
14. vWF multimer assay 2015.
15. Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood 2015, 125:616-618.
16. Reese JA, Bougie DW, Curtis BR, Terrell DR, Vesely SK, Aster RH, et al. Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol 2015, 90:406-410.
17. Bougie DW, Birenbaum J, Rasmussen M, Poncz M, Aster RH Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopenia. Blood 2009, 113:1105-1111.
18. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008, 358:1129-1136.
19. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 2000, 132:794-799.
20. Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, et al. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl 2009, 112:S20-4. 10.1038/ki.2008.613.
21. Perdue JJ, Chandler LK, Vesely SK, Duvall DS, Gilcher RO, Smith JW, et al. Unintentional platelet removal by plasmapheresis. J Clin Apher 2001, 16:55-60.